FHIRsmith: FHIR Resources

FHIR IG analytics

Version: All | R2 | R2B | R3 | R4 | R4B | R5 | R6
Authority: All | hl7 | ihe | national
Realm: All | au | be | br | ca | ch | cl | cr | cz | de | dk | ee | eu | fi | fr | il | in | it | jp | kr | nl | no | nz | pl | pt | se | stt | tw | uk | us | uv
View: All | Resource Profiles | Datatype Profiles | Extensions | Logical Models | CodeSystems | ValueSets | ConceptMaps

Resources - All Kinds, Realm US, Authority Hl7

19,236 resources

Type: Text:

By Version

R2: 0
R2B: 0
R3: 568
R4: 17,736
R4B: 121
R5: 810
R6: 1

Start Prev Rows 8000 - 8200 Next

Package	Version	Identity	Name/Title	Status	Date
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.837.json	Tetracyclines	active	2024-02
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.838.json	Phosphonics	active	2024-02
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.839.json	Pleuromutilin	active	2024-02
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.840.json	Streptogramins	active	2024-02
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.841.json	Lipoglycopeptides	active	2024-02
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.842.json	Nitroimidazoles	active	2024-02
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.843.json	PIM_Hyd_Bus_Mir_Tra	active	2024-02
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.844.json	Nitrofurans	active	2024-02
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.845.json	Rifamycins	active	2024-02
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.846.json	Glycylcycline	active	2024-02
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.847.json	Pyrimidines	active	2024-02
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.849.json	Antibiotics oral and parenteral	active	2024-02
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.850.json	Medications_hyperkalemia	active	2024-03
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.852.json	Hyperkalemia_ICD10	active	2024-02
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.853.json	Hyperkalemia_SCT	active	2024-02
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.854.json	Hyperkalemia Conditions	active	2024-02
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.855.json	Medications_Chronic Hyperkalemia	active	2024-02
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.858.json	PIM_Alpha_Blockers_2	active	2024-03
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.860.json	PIM_Ambulatory_Visits_CPTs	active	2024-03
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.862.json	PIM_Ambulatory_Visits_SNOMED	active	2024-03
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.863.json	PIM_Thyroid_Stimulating_Hormone_(TSH)	active	2024-03
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.864.json	PIM_Triiodothyronine_(T3)	active	2024-03
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.865.json	PIM_Thyroxine_(T4)	active	2024-03
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.866.json	PIM_Magnesium_LOINC	active	2024-03
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.867.json	PIM_BMP_CMP_LOINC	active	2024-03
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.868.json	PIM_URIC_ACID_LOINC	active	2024-03
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.869.json	PIM_Migraine_Medications	active	2025-04
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.870.json	PIM_Triptans	active	2024-03
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.871.json	ICS_SABA Reliever	active	2024-06
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.873.json	PIM_Asthma_COPD_Meds	active	2025-03
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.874.json	PIM_Lipid_Panel_CPTs	active	2024-03
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.875.json	PIM_Hepatic_Function_Panel_CPTs	active	2024-03
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.876.json	Alpha Glucosidase Allergy Intolerance	active	2025-04
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.877.json	Inflammatory bowel disease I10	active	2024-04
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.878.json	Inflammatory bowel disease SCT	active	2024-04
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.879.json	Inflammatory bowel disease	active	2024-04
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.880.json	Gastrointestinal obstruction SCT	active	2024-04
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.881.json	Gastrointestinal obstruction I10	active	2024-04
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.882.json	Gastrointestinal obstruction	active	2024-04
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.883.json	DPP4i Allergy Intolerance	active	2025-04
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.884.json	Multiple endocrine neoplasia type 2 (MEN II) SCT	active	2024-04
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.885.json	Multiple endocrine neoplasia type 2 (MEN II) I10	active	2024-04
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.886.json	Multiple endocrine neoplasia type 2 (MEN II)	active	2024-04
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.887.json	Gastroparesis SCT	active	2024-04
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.888.json	Gastroparesis I10	active	2024-04
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.889.json	Gastroparesis	active	2024-04
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.890.json	Meglitinide Allergy Intolerance	active	2025-04
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.891.json	Sulfonylurea Allergy Intolerance	active	2025-04
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.892.json	Peripheral edema I10	active	2024-04
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.893.json	Peripheral edema SCT	active	2024-04
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.894.json	Peripheral edema	active	2024-04
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.895.json	TZD Allergy Intolerance	active	2025-05
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.896.json	PIM_Beta_Blockers	active	2024-11
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.897.json	PIM_CCB_DHPs	active	2024-11
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.898.json	PIM_Loop_Diuretics	active	2024-04
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.899.json	PIM_Inhaled_Corticosteroids_(ICS)	active	2025-03
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.9.json	ACE inhibitors	active	2024-12
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.90.json	ASCVD I10	active	2023-09
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.900.json	PIM_Leukotrienes	active	2024-04
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.901.json	OIA_Asthma_COPD_Meds_Inhalers	active	2025-04
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.902.json	OIA_Asthma_COPD_Meds_Nebulizers	active	2024-04
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.903.json	OIA_Asthma_COPD_Meds_Oral	active	2024-04
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.904.json	OIA_GLP1_Injectables	active	2024-04
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.905.json	OIA_Insulin_Injectables	active	2024-04
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.906.json	OIA_Oral_Hypoglycemics	active	2024-12
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.907.json	OIA_DM1_DM2_Meds	active	2024-10
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.908.json	Medium Dose ICS Formoterol	active	2024-05
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.909.json	High Dose ICS Formoterol	active	2024-05
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.910.json	CKD stage5OrESRD I10	active	2024-05
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.911.json	CKD stage5OrESRD SCT	active	2024-05
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.912.json	CKD stage5OrESRD	active	2024-05
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.914.json	Anxiety_I10	active	2024-06
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.915.json	Anxiety_SCT	active	2024-06
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.916.json	Anxiety	active	2024-06
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.918.json	Stress_SCT	active	2024-06
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.919.json	Stress_I10	active	2024-06
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.920.json	Stress	active	2024-06
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.921.json	PBH_Anxiety_SCT	active	2024-06
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.922.json	PBH_Depression_SCT	active	2024-06
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.923.json	PBH_Stress_SCT	active	2024-06
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.924.json	PBH_Insomnia_SCT	active	2024-06
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.925.json	PIM_CMP_CPTs	active	2024-06
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.926.json	Canagliflozin meds	active	2024-07
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.927.json	Empagliflozin meds	active	2024-07
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.928.json	Dapagliflozin meds	active	2024-07
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.929.json	Ertugliflozin meds	active	2024-07
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.930.json	Dulaglutide meds	active	2024-07
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.931.json	Liraglutide meds	active	2024-07
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.932.json	Semaglutide SC meds	active	2024-07
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.933.json	T2DM meds benefitting ASCVD	active	2024-07
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.934.json	T2DM meds benefitting CKD stages 2, 3, and 4 with eGFR >= 20 mL/min	active	2024-07
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.935.json	T2DM meds benefitting CKD stage 5	active	2024-07
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.936.json	T2DM meds benefitting HF with eGFR >= 20 mL/min	active	2024-07
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.938.json	Crohn disease SCT	active	2024-10
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.939.json	Crohn disease I10	active	2024-10
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.940.json	Crohn disease	active	2024-10
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.941.json	Celiac disease SCT	active	2024-10
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.942.json	Celiac disease I10	active	2024-10
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.943.json	Celiac disease	active	2024-10
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.944.json	OIA_Bisoprolol	active	2024-10
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.945.json	OIA_PVD_ICD10	active	2024-10
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.946.json	Vibration Controlled Transient Elastography (VCTE)	active	2024-12
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.947.json	OIA_Antihypertensive_Medications	active	2024-10
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.950.json	OIA_CAD_ICD10	active	2024-10
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.951.json	OIA_DM_ICD10	active	2024-10
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.952.json	OIA_Creatinine_Levels_LOINC	active	2024-10
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.953.json	OIA_DM_SNOMEDCT	active	2024-10
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.954.json	OIA_CAD_SNOMEDCT	active	2024-10
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.955.json	OIA_PVD_SNOMEDCT	active	2024-10
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.956.json	OIA_DM_ICD10_SNOMEDCT	active	2024-10
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.957.json	OIA_CAD_ICD10_SNOMEDCT	active	2024-10
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.958.json	OIA_PVD_ICD10_SNOMEDCT	active	2024-10
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.959.json	ACEi for HFrEF	active	2025-01
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.960.json	ARB for HFrEF	active	2024-12
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.961.json	OIA_AntiHTN_Meds_Inclusion_List	active	2024-11
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.962.json	OIA_Thiazide_Diuretics	active	2024-11
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.963.json	OIA_RFs_ACS_ICD10	active	2024-12
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.964.json	OIA_RFs_ACS_SNOMED	active	2024-12
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.965.json	OIA_RFs_ACS__ICD10_SNOMED	active	2024-12
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.966.json	OIA_Aortic_Calcifications_ICD10	active	2025-01
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.967.json	OIA_Aortic_Calcifications_SNOMED	active	2025-01
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.968.json	OIA_Aortic_Calcifications_ICD10_SNOMED	active	2025-01
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.969.json	OIA_Microalbumin	active	2025-01
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.97.json	Sulfonylurea AllergyIntolerance SCT	active	2023-09
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.970.json	OIA_LDL_Cholesterol	active	2025-01
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.971.json	Pioglitazone	active	2025-01
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.972.json	MASLD I10	active	2025-02
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.973.json	MASLD SCT	active	2025-02
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.975.json	OIA_Sulfonylureas	active	2025-01
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.978.json	OIA_RFs_ASCVD_ICD10	active	2025-01
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.979.json	OIA_RFs_ASCVD_SNOMED	active	2025-01
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.98.json	BMI LOINC	active	2024-03
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.980.json	OIA_RFs_ASCVD_ICD10_SNOMED	active	2025-01
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.981.json	OIA_TIA_ICD10	active	2025-01
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.982.json	OIA_TIA_SNOMED	active	2025-01
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.983.json	OIA_TIA_ICD10_SNOMED	active	2025-01
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.984.json	OIA_Angina_ICD10	active	2025-01
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.985.json	OIA_Angina_SNOMED	active	2025-01
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.987.json	OIA_Angina_ICD10_SNOMED	active	2025-01
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.988.json	OIA_Ischemic_Hemorrhagic_Stroke_ICD10	active	2025-01
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.989.json	OIA_Ischemic_Hemorrhagic_Stroke_SNOMED	active	2025-01
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.990.json	OIA_Ischemic_Hemorrhagic_Stroke_ICD10_SNOMED	active	2025-01
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.991.json	OIA_Myocardial_Infarction_ICD10	active	2025-01
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.992.json	OIA_Myocardial_Infarction_SNOMED	active	2025-01
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.993.json	OIA_Myocardial_Infarction_ICD10_SNOMED	active	2025-01
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.995.json	OIA_PAD_ICD10	active	2025-01
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.996.json	OIA_PAD_SNOMED	active	2025-01
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.997.json	OIA_PAD_ICD10_SNOMED	active	2025-01
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.998.json	OIA_Coronary_Arterial_Revascularization	active	2025-01
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1080.5.json	Contact or Office Visit	active	2022-02
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1080.6.json	Contact or Office Visit	active	2025-02
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1080.7.json	Contact or Office Visit	active	2022-02
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.10.json	Nutrition Diagnosis SNOMED CT	active	2025-01
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.101.json	Hospice Status	active	2024-10
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.14.json	Vitamin Mineral Supplement and Bioactive Substance Management SNOMED CT	active	2020-08
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.17.json	Pediatric Enteral Formulas SNOMED CT	active	2021-04
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.18.json	Modified Amino Acid Formulas SNOMED CT	active	2024-04
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.19.json	Nutrition Counseling Approach and Strategies SNOMED CT	active	2020-09
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.20.json	Enteral Nutrition Management SNOMED CT	active	2020-09
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.21.json	Nutrition Assessment	active	2024-01
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.25.json	Nutritional Status Severely Malnourished	active	2016-12
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.30.json	Malnutrition Risk Screening	active	2015-11
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.31.json	Malnutrition At Risk	active	2015-11
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.32.json	Malnutrition Risk Screening	active	2016-12
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.34.json	Malnutrition Screening Finding of Not At Risk Result	active	2024-01
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.35.json	Malnutrition Screening Not at Risk	active	2015-11
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.38.json	Malnutrition Screening Finding of At Risk Result	active	2025-01
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.39.json	Malnutrition Risk Screening	active	2016-12
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.40.json	Malnutrition Risk Screening	active	2022-02
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.41.json	Nutritional Status Severely Malnourished	active	2025-02
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.42.json	Nutrition Assessment Status Finding of Severely Malnourished	active	2024-12
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.43.json	Nutrition Assessment Status Finding of Severely Malnourished	active	2024-01
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.44.json	Nutrition Assessment Status Finding of Moderately Malnourished	active	2024-01
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.45.json	Nutritional Status Moderately Malnourished	active	2015-11
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.46.json	Nutritional Status Moderately Malnourished	active	2025-02
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.47.json	Nutrition Assessment Status Finding of Moderately Malnourished	active	2024-01
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.48.json	Nutrition Assessment Status Finding of Well Nourished or Not Malnourished or Mildly Malnourished	active	2024-01
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.49.json	Nutrition Focused Physical Findings Grouping	active	2022-03
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.5.json	Adult Enteral Formulas SNOMED CT	active	2024-04
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.50.json	Enteral Nutrition Composition SNOMED CT	active	2024-04
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.51.json	Enteral Nutrition Composition Grouping	active	2022-03
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.52.json	Parenteral Nutrition Management SNOMED CT	active	2020-09
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.53.json	Malnutrition Diagnosis	active	2024-12
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.54.json	Malnutrition Diagnosis	active	2025-02
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.55.json	Malnutrition Diagnosis	active	2022-03
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.56.json	Malnutrition Diagnosis	active	2016-09
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.59.json	Diet Item Grouping	active	2018-04
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.60.json	Edible Substances	active	2021-04
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.61.json	Feeding Device SNOMED CT	active	2021-04
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.65.json	Nutrition Recommendation Grouping	active	2025-02
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.7.json	Modular Nutrition Formulas SNOMED CT	active	2021-04
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.71.json	Coordination of Care by a Nutrition Professional SNOMED CT	active	2024-04
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.73.json	Nutrition Anthropometric Measurement SNOMED CT	active	2024-05
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.74.json	Nutrition Anthropometric Measure Panel LOINC	active	2024-05
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.75.json	Nutrition Anthropometric Measurements Grouping	active	2018-04
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.76.json	Manage Feeding Environment	active	2021-04
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.77.json	Special Food Items and Regime/Therapy for Special Food Items SNOMED CT	active	2021-04
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.78.json	Food and Nutrition Related History LOINC	active	2024-04
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.79.json	Nutrition Encounter Individual and Group CPT	active	2025-02
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.80.json	Nutrition Encounters HCPCS	active	2025-02